Profile data is unavailable for this security.
About the company
Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.
- Revenue in USD (TTM)115.33k
- Net income in USD-7.86m
- Incorporated2009
- Employees8.00
- LocationArch Therapeutics Inc235 Walnut Street, Suite 6FRAMINGHAM 01702United StatesUSA
- Phone+1 (617) 431-2313
- Websitehttps://www.archtherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tenon Medical Inc | 2.93m | -15.58m | 3.17m | 21.00 | -- | 2.84 | -- | 1.08 | -10.28 | -10.28 | 1.62 | 0.2992 | 0.3359 | 3.48 | 7.85 | 139,428.60 | -178.74 | -- | -264.89 | -- | 42.38 | -- | -532.14 | -- | 1.06 | -- | 0.6012 | -- | 323.73 | -- | 17.63 | -- | -- | -- |
| Sharps Technology Inc | 0.00 | -9.84m | 3.61m | 3.00 | -- | 0.4432 | -- | -- | -0.7645 | -0.7645 | 0.00 | 0.5195 | 0.00 | -- | -- | -- | -83.30 | -- | -109.78 | -- | -- | -- | -- | -- | 0.8474 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Aethlon Medical, Inc. | 574.25k | -12.26m | 3.64m | 15.00 | -- | 0.4742 | -- | 6.34 | -5.03 | -5.03 | 0.2362 | 2.93 | 0.0369 | -- | -- | 38,283.33 | -78.62 | -75.30 | -92.02 | -84.98 | -- | -- | -2,133.17 | -1,783.78 | -- | -- | 0.00 | -- | 95.21 | 30.86 | -15.55 | -- | 106.99 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 3.71m | 9.00 | -- | -- | -- | 2.30 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| ReShape Lifesciences Inc | 8.68m | -11.39m | 3.97m | 31.00 | -- | 0.596 | -- | 0.4576 | -3.77 | -3.77 | 1.46 | 0.2841 | 0.796 | 0.8515 | 4.52 | 279,935.50 | -104.44 | -136.06 | -215.93 | -194.32 | 63.93 | 56.30 | -131.22 | -408.36 | 1.74 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Innovative Eyewear Inc | 1.15m | -6.66m | 4.02m | 11.00 | -- | 0.5345 | -- | 3.49 | -0.6442 | -0.6442 | 0.1098 | 0.4303 | 0.2113 | 4.05 | 11.33 | 104,770.90 | -122.17 | -- | -137.62 | -- | -10.35 | -- | -578.18 | -- | 8.14 | -2,255.11 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| Catheter Precision Inc | 442.00k | -71.37m | 4.24m | 14.00 | -- | 0.1857 | -- | 9.60 | -25.32 | -25.32 | 0.0806 | 3.02 | 0.0186 | 1.36 | 6.45 | 31,571.43 | -296.70 | -- | -376.14 | -- | 93.21 | -- | -15,966.52 | -- | 1.67 | -- | 0.0086 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
| Acutus Medical Inc | 7.16m | -11.92m | 4.30m | 233.00 | -- | -- | -- | 0.6003 | -0.4097 | -0.417 | 0.2467 | -0.0308 | 0.0765 | 1.17 | 0.4417 | 30,746.78 | -12.72 | -46.76 | -16.05 | -56.88 | -43.79 | -89.12 | -166.40 | -773.49 | 2.22 | -6.78 | 1.03 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| Encision Inc | 6.87m | -448.00k | 4.32m | 31.00 | -- | 1.97 | -- | 0.6293 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| Venus Concept Inc | 76.35m | -37.25m | 4.34m | 304.00 | -- | -- | -- | 0.0569 | -6.86 | -6.86 | 14.05 | -2.54 | 0.6972 | 1.03 | 2.30 | 251,164.50 | -33.83 | -32.71 | -50.39 | -44.01 | 68.32 | 68.16 | -48.52 | -48.50 | 1.39 | -3.93 | 1.22 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Arch Therapeutics Inc | 115.33k | -7.86m | 4.39m | 8.00 | -- | -- | -- | 38.04 | -4.07 | -4.07 | 0.0509 | -2.02 | 0.0652 | 0.0613 | -- | 14,416.25 | -444.57 | -188.28 | -- | -804.63 | 27.04 | -- | -6,819.08 | -26,945.92 | 0.042 | -2.02 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 4.80m | 15.00 | -- | -- | -- | 2.11 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
| BIOLASE Inc | 49.16m | -37.62m | 4.83m | 157.00 | -- | -- | -- | 0.0982 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 5.55m | 7.00 | -- | 5.03 | -- | 1.95 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Guided Therapeutics Inc | 98.00k | -3.76m | 5.56m | 4.00 | -- | -- | -- | 56.75 | -0.074 | -0.074 | 0.0019 | -0.0703 | 0.0389 | 0.1051 | 15.08 | 24,500.00 | -138.59 | -136.13 | -- | -- | 36.73 | 29.39 | -3,560.20 | -3,666.67 | 0.1582 | -12.94 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Heart Test Laboratories Inc | 18.60k | -6.39m | 5.82m | 12.00 | -- | 0.6543 | -- | 313.00 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Arch Therapeutics Inc's reporting currency: US Dollar USD
6.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Cavalry Fund I Management LLCas of 18 Jul 2023 | 300.00k | 6.33% |
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
